<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="0" ids="35664">Statins</z:chebi> are widely used in the primary and secondary prevention of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, but their effects on <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced immunodepression and poststroke <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> are elusive </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effects of <z:chebi fb="0" ids="9150">simvastatin</z:chebi> treatment on <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:mp ids='MP_0003643'>splenic atrophy</z:mp> and lung susceptibility to <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in <z:hpo ids='HP_0011009'>acute</z:hpo> experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> in mice </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: <z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> was induced by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, followed by reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>In some experiments, splenectomies were performed 2 weeks before middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were randomly assigned to sham and middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> groups treated subcutaneously with vehicle or <z:chebi fb="0" ids="9150">simvastatin</z:chebi> (20 mg/kg per day) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">Brain infarction</z:e>, neurological function, brain interferon-γ expression, <z:mp ids='MP_0003643'>splenic atrophy</z:mp> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and <z:e sem="disease" ids="C0876973" disease_type="Disease or Syndrome" abbrv="">lung infection</z:e> were examined </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="0" ids="9150">Simvastatin</z:chebi> reduced <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:mp ids='MP_0003643'>spleen atrophy</z:mp> and splenic <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via increased mitochrondrial antiapoptotic Bcl-2 expression and decreased proapoptotic Bax translocation from cytosol into mitochondria </plain></SENT>
<SENT sid="7" pm="."><plain>Splenectomy reduced brain interferon-γ (3 days) and <z:mpath ids='MPATH_124'>infarct</z:mpath> size (5 days) after <z:hpo ids='HP_0001297'>stroke</z:hpo>, and these effects were reversed by adoptive transfer of splenocytes </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="9150">Simvastatin</z:chebi> inhibited brain interferon-γ (3 days) and reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and neurological deficits (5 days) after <z:hpo ids='HP_0001297'>stroke</z:hpo>, and these protective effects were observed not only in naive <z:hpo ids='HP_0001297'>stroke</z:hpo> mice but also in splenectomied <z:hpo ids='HP_0001297'>stroke</z:hpo> mice adoptively transferred with splenocytes </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="9150">Simvastatin</z:chebi> also decreased the <z:hpo ids='HP_0001297'>stroke</z:hpo>-associated lung susceptibility to spontaneous <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Results provide the first direct experimental evidence that <z:chebi fb="0" ids="9150">simvastatin</z:chebi> ameliorates <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced peripheral immunodepression by attenuating <z:mp ids='MP_0003643'>spleen atrophy</z:mp> and lung <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These findings contribute to a better understanding of the beneficial effects of <z:chebi fb="0" ids="35664">statins</z:chebi> in the treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>